Aurinia Pharmaceuticals
AUPH
16.01
+0.32
+2.04%
Aurinia Pharmaceuticals
US · AUPH
#2749 by market cap
Listed 1970
16.01
+0.32
+2.04%
Live - 5344 symbols - heartbeat 493s ago
· 2026-10-08 08:17
Pre-market
16.05
+0.25%
After-hours
16.01
0.00%
- Market cap
- 2.13B
- P/E (TTM)i
- 7.02
- P/Bi
- 3.46
- EPSi
- 2.07
- Div yieldi
- 0.00%
- 52W posi
- 61%
Reader sentiment
Are you bullish or bearish on AUPH?
Anonymous reader poll. Unscientific, not investment advice.
About Aurinia Pharmaceuticals
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
- Founded
- 1993
- CEO
- Mr. Kevin C. Tang
- Employees
- 128
- Headquarters
- Edmonton, Alberta, Canada
- Fiscal year end
- 12-31
- Website
- auriniapharma.com
Company profile
- Exchange
- US
- Symbol
- AUPH
- Market-cap rank
- #2749
- Listing date
- 1970-01-01
- Market cap
- 2.13B
- Float cap
- 2.07B
- Shares out
- 133.05M
- Float shares
- 129.22M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 08:17:43 · For reference only, not investment advice and not tailored to your situation.